首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1581篇
  免费   85篇
  1666篇
  2022年   16篇
  2021年   22篇
  2020年   12篇
  2019年   22篇
  2018年   18篇
  2017年   19篇
  2016年   25篇
  2015年   57篇
  2014年   58篇
  2013年   80篇
  2012年   101篇
  2011年   77篇
  2010年   70篇
  2009年   68篇
  2008年   114篇
  2007年   98篇
  2006年   82篇
  2005年   77篇
  2004年   103篇
  2003年   95篇
  2002年   90篇
  2001年   23篇
  2000年   25篇
  1999年   23篇
  1998年   13篇
  1997年   16篇
  1996年   15篇
  1995年   14篇
  1994年   14篇
  1993年   14篇
  1992年   21篇
  1991年   15篇
  1990年   15篇
  1989年   17篇
  1988年   7篇
  1987年   8篇
  1986年   13篇
  1985年   6篇
  1984年   8篇
  1983年   9篇
  1982年   13篇
  1981年   7篇
  1980年   7篇
  1979年   5篇
  1975年   7篇
  1974年   7篇
  1973年   6篇
  1971年   4篇
  1968年   4篇
  1967年   4篇
排序方式: 共有1666条查询结果,搜索用时 15 毫秒
991.
992.
The optogenetic manipulation of light-activated ion-channels/pumps (i.e., opsins) can reversibly activate or suppress neuronal activity with precise temporal control. Therefore, optogenetic techniques hold great potential to establish causal relationships between specific neuronal circuits and their function in freely moving animals. Due to the critical role of the hippocampal CA1 region in memory function, we explored the possibility of targeting an inhibitory opsin, ArchT, to CA1 pyramidal neurons in mice. We established a transgenic mouse line in which tetracycline trans-activator induces ArchT expression. By crossing this line with a CaMKIIα-tTA transgenic line, the delivery of light via an implanted optrode inhibits the activity of excitatory CA1 neurons. We found that light delivery to the hippocampus inhibited the recall of a contextual fear memory. Our results demonstrate that this optogenetic mouse line can be used to investigate the neuronal circuits underlying behavior.  相似文献   
993.
Essentially every population of cancer cells within a tumor is heterogeneous, especially with regard to chemosensitivity and resistance. In the present study, we utilized the fluorescence ubiquitination-based cell cycle indicator (FUCCI) imaging system to investigate the correlation between cell-cycle behavior and apoptosis after treatment of cancer cells with chemotherapeutic drugs. HeLa cells expressing FUCCI were treated with doxorubicin (DOX) (5 μM) or cisplatinum (CDDP) (5 μM) for 3 h. Cell-cycle progression and apoptosis were monitored by time-lapse FUCCI imaging for 72 h. Time-lapse FUCCI imaging demonstrated that both DOX and CDDP could induce cell cycle arrest in S/G2/M in almost all the cells, but a subpopulation of the cells could escape the block and undergo mitosis. The subpopulation which went through mitosis subsequently underwent apoptosis, while the cells arrested in S/G2/M survived. The present results demonstrate that chemoresistant cells can be readily identified in a heterogeneous population of cancer cells by S/G2/M arrest, which can serve in future studies as a visible target for novel agents that kill cell-cycle-arrested cells.  相似文献   
994.
995.
996.
Nucleostemin is a nucleolar protein known to play a variety of roles in cell-cycle progression, apoptosis inhibition, and DNA damage protection in embryonic stem cells and tissue stem cells. However, the role of nucleostemin in hematopoietic stem cells (HSCs) is yet to be determined. Here, we identified an indispensable role of nucleostemin in mouse HSCs. Depletion of nucleostemin using short hairpin RNA strikingly impaired the self-renewal activity of HSCs both in vitro and in vivo. Consistently, nucleostemin depletion triggered apoptosis rather than cell-cycle arrest in HSCs. Furthermore, DNA damage accumulated during cultivation upon depletion of nucleostemin. The impaired self-renewal activity of HSCs induced by nucleostemin depletion was partially rescued by p53 deficiency but not by p16Ink4a or p19Arf deficiency. Taken together, our study demonstrates that nucleostemin protects HSCs from DNA damage accumulation and is required for the maintenance of HSCs.  相似文献   
997.
998.
The reduction of 2, 6-dichlorophenolindophenol by triose reductone was studied in a wide pH range (pH 2~11), using a stopped-flow apparatus. The apparent first-order rate constant, kapp, and the second-order rate constant, k, were obtained. The k-pH profile resembles that of l-ascorbic acid, though the rate of l-ascorbic acid is considerably larger than that of triose reductone. Determination of triose reductone by stopped-flow method is possible, even in the presence of various organic substances.  相似文献   
999.
The inactivation of the enzymes by linoleic acid hydroperoxides (LAHPO) was tested in connection with the toxicity of oxidized fat. At the same time, the inhibition of enzyme activities by linoleic acid was also tested. Ribonuclease (RNase), trypsin, chymotrypsin and pepsin which are considered to be simple proteins and not to be SH-enzymes were chosen as the enzymes. RNase was largely inhibited by LAHPO, but the other enzymes were inhibited by linoleic acid as well as LAHPO. The inhibition of each enzyme occurred at different pH. This fact may show that the inhibition occurs by binding of such hydrophobic compounds to the enzyme, and that the surface exposition of hydrophobic region may depend on the pH. Not only the reaction of some specific amino acid residue in the protein molecules with LAHPO, but also the binding of these hydrophobic compounds must be remembered in the mechanism of inhibition.  相似文献   
1000.
A prolidase with a molecular weight of 43,000 was purified to homogeneity from a cell-free extract of Streptococcus cremoris H61. The optimum pH of the enzyme was in the range of 6.5 to 7.5. The hydrolyzing activity was specific for dipeptides of the X-Pro type. Kinetic constants for 4 dipeptides (Leu-Pro, Phe-Pro, Val-Pro and Ala-Pro) were estimated. Km values were not very different for these substrates, but Vmax values were quite different (Leu-Pro > Phe-Pro, Val-Pro > Ala-Pro). The enzyme was activated by cobalt ion and inactivated by metal-chelating agents or with 2-mercaptoethanol.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号